NCT00293254 A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019) Status COMPLETED Phase PHASE3
NCT00292071 Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) Status COMPLETED Phase PHASE2
NCT00290550 A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006) Status TERMINATED Phase PHASE2
NCT00289913 Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068) Status COMPLETED Phase PHASE4
NCT00289900 Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) Status COMPLETED Phase PHASE3
NCT00289848 MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040) Status COMPLETED Phase PHASE3
NCT00288431 Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015) Status COMPLETED Phase PHASE1
NCT00282763 A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005) Status TERMINATED Phase PHASE2
NCT00282386 A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122) Status COMPLETED Phase PHASE3
NCT00275652 A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. Status COMPLETED Phase PHASE3
NCT00274716 Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00266812 Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED) Status TERMINATED Phase PHASE2
NCT00266799 The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071) Status COMPLETED Phase PHASE3
NCT00265395 Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685) Status COMPLETED Phase PHASE3
NCT00265252 Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis Status UNKNOWN Phase PHASE4